Announcements Trials
Browse Landscape

Phase

Phase 2/3 2Phase 1/2 1Phase 1 1

Status

Completed 4

Sponsor Class

OTHER 25NETWORK 13NIH 7INDUSTRY 4

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 1Extravasations of Anthracycline Anti-cancer Agents 1Extravasation 1Anthracycline Extravasation 1

Interventions

pembrolizumab 1019Carboplatin 959Paclitaxel 932Gemcitabine 793Cisplatin 748Docetaxel 682Bevacizumab 610Pemetrexed 502Nivolumab 486Cyclophosphamide 466Capecitabine 461Fluorouracil 417Dexamethasone 402Rituximab 372Oxaliplatin 347Injections 342atezolizumab 297Trastuzumab 297Leucovorin 286Cetuximab 282Irinotecan 266130-nm albumin-bound paclitaxel 252Prednisone 244Doxorubicin 240Ipilimumab 226Lenalidomide 220Fulvestrant 217fludarabine 214durvalumab 205Erlotinib Hydrochloride 188

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
INDUSTRY × Interventional × Dexrazoxane × Clear all
NCT05858710 2025-07-28

Study of DPPG2-TSL-DOX Combined With Hyperthermia in Soft Tissue Sarcoma

Thermosome GmbH

Phase 1 Completed
8 enrolled
Sarcoma

Sarcoma

NCT00548561 2015-10-21

Efficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines

Valerio Therapeutics

Phase 2/3 Completed
23 enrolled

Anthracycline Extravasation

NCT00548704 2015-10-21

A Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines

Valerio Therapeutics

Phase 2/3 Completed
57 enrolled

Extravasation

NCT01596088 2015-04-07

A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

Kissei Pharmaceutical Co., Ltd.

Phase 1/2 Completed
2 enrolled 6 charts

Extravasations of Anthracycline Anti-cancer Agents

Data powered by HemOnc (CC BY 4.0) Colophon âš¡